Paul Michas, MD
Orthopaedic Surgery · Albany, GANPI 1750355574
Payments from drug & device makers
Across 186 payments — averaging $122.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$12K
- CGG Medical Inc$9K
- Organogenesis Inc.$451
- DJO, LLC$302
- Amgen$238
- Boston Scientific$230
- plus $807 from 16 others
What the payments were for
- Travel & lodging$7,08931%
- Food & beverage$4,03018%
- Education$11,72951%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 73 | $12,266 |
| CGG Medical Inc | 23 | $8,553 |
| Organogenesis Inc. | 15 | $451 |
| DJO, LLC | 10 | $302 |
| Amgen(2 entities) | 23 | $238 |
| Boston Scientific | 2 | $230 |
| Pacira Therapeutics, Inc. | 10 | $163 |
| Bioventus LLC | 6 | $145 |
| Johnson & Johnson | 3 | $76 |
| Smith+Nephew | 3 | $66 |
| Zimmer Biomet | 3 | $61 |
| Pacira Pharmaceuticals Incorporated | 3 | $60 |
| Baxter Healthcare | 2 | $52 |
| Si-bone, Inc. | 2 | $34 |
| Convatec Inc. | 1 | $23 |
| Avanos Medical | 1 | $23 |
| Moximed, Inc | 1 | $22 |
| Innovation Technologies Inc | 1 | $20 |
| Vertex | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Baudax Bio Inc. | 1 | $14 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$247
- GENERAL PAIN MANAGEMENT$118
- WAVEWRITER ALPHA$112
How this compares
$22,847 in reported general payments places this provider in the 80th percentile of 654 orthopaedic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Piroxicam | 16 | $9,120 |
| Calcipotriene | 16 | $5,215 |
| Diclofenac Sodium | 47 | $816 |
| Ondansetron OdtOndansetron | 60 | $618 |
| Methylprednisolone | 91 | $516 |
| Gabapentin | 43 | $441 |
| Ibuprofen | 72 | $386 |
| Celecoxib | 16 | $345 |
| Meloxicam | 66 | $298 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 50 | $211 |
| Tizanidine Hcl | 32 | $95 |
| Tramadol Hcl | 60 | $75 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Albany
- Charles DecookCumming$48.3M
- Ormonde MahoneyAthens$10.8M
- Daxes BanitWarner Robins$5.7M
- John DorchakColumbus$3.8M
- Daniel SilcoxAtlanta$3.4M
- Dennis DevitoAtlanta$1.5M
- George GuildCumming$1.4M
- Jon MinterAlpharetta$1.4M
- Tuan BuiLawrenceville$1.1M
- William TallyAthens$870K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.